Crystal structure of vancomycin

Structure

Volumn 4, Issue 12, 1996, Pages 1509-1515

  Schäfer, Martina ^a   Schneider, Thomas R ^b,c   Shieldrick, George M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

ab initio structure solution; cryocrystallography; crystal structure; glycopeptide antibiotics; vancomycin

Indexed keywords

EID: 0030589727     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(96)00156-6     Document Type: Article

References (30)

1. Barna, J.C.J. & Williams, D.H. (1984). The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Ann. Rev. Microbiol. 38, 339-357.
2. Reynolds, P.E. (1989). Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Microb. Infect. Dis. 8, 943-950.
3. Brant, M., Wingert, P. & Hager, P. (1994). The end of antibiotics? Newsweek 123, 38-43.
4. Neu, H.C. (1992). The crisis in antibiotic resistance. Science 257, 1064-1073.
5. Arthur, M. & Courvalin, P. (1993). Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37, 1563-1571.
6. Walsh, C.T. (1993). Vancomycin resistance - decoding the molecular logic. Science 261, 308-309.
7. Walsh, C.T., Fisher, S.I., Park, I-S., Prahalad, M. & Wu, Z. (1996). Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem. Biol. 3, 21-28.
8. Waitho, J.P. & Williams, D.H. (1989). Aspects of molecular recognition: solvent exclusion and dimerization of the antibiotic ristocetin when bound to a model bacterial cell wall precursor. J. Am. Chem. Soc. 111, 2475-2480.
9. Gerhard, U., MacKay, J.P., Maplestone, R.A. & Williams, D.H. (1993). The role of the sugar and chlorine substituents in the dimerisation of vancomycin antibiotics. J. Am. Chem. Soc. 115, 232-237.
10. Groves, P., Searle, M.S., MacKay, J.P. & Williams, D.H. (1994). The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics. Structure 2, 747-754.
11. MacKay, J.P., Gerhard, U., Beauregard, D.A., Westweil, M.S., Searle, M.S. & Williams, D.H. (1994). Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling. J. Am. Chem. Soc. 116, 4581-4590.
12. 13C NMR spectrum of vancomycin. J. Chem. Soc. Perkin Trans. II 153-158.
13. 13C NMR spectroscopy. J. Chem. Soc. Perkin Trans. II 159-162.
14. Beauregard, D.A., Williams, D.H., Gwynn, M.N., Knowles, D.J.C. (1995). Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob. Agents Chemotherapy 39, 781-785.
15. Sheldrick, G.M., Jones, P.G., Kennard, O., Williams, D.H. & Smith, G.A. (1978). Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine. Nature 271, 223-225.
16. Harris, C.M., Kopecka, H. & Harris, T.M. (1983). Vancomycin: structure and transformation to CDP-1. J. Am. Chem. Soc. 105, 6915-6922.
17. Williamson, M.P. & Williams, D.H. (1981). Structural revision of the antibiotic vancomycin. The use of nuclear Overhauser effect difference spectroscopy. J. Am. Chem. Soc. 103, 6580-6585.
18. Sheldrick, G.M., Paulus, E., Vértesy, L & Hahn, F. (1995). Structure of ureido-balhimycin. Acta Cryst. B 51, 89-98.
19. Sheldrick, G.M., Dauter, Z., Wilson, K.S., Hope, H. & Sieker, L.C. (1993). The application of direct methods and Patterson interpretation to high resolution native protein data. Acta Cryst. D 49, 18-23.
20. Sheldrick, G.M. (1990). Phase annealing in SHELX-90: direct methods for larger structures. Acta Cryst. A 46, 467-473.
21. Miller, R., DeTitta, G.T., Jones, R., Langs, D.A., Weeks, C.M. & Hauptman, H.A. (1993). On the application of the minimal principle to solve unknown structures. Science 259, 1430-1433.
22. Miller, R., Gallo, S.M., Khalak, H.G. & Weeks, C.M. (1994). SnB: crystal structure determination via Shake-and-Bake. J. Appl. Cryst. 27, 613-621.
23. Sheldrick, G.M. & Gould, R.O. (1995). Structure solution by iterative peaklist optimization and tangent expansion in space group P1. Acta Cryst. B 51, 423-431.
24. Fujinaga, M. & Read, R.J. (1987). Experiences with a new translation-function program. J. Appl. Cryst. 20, 517-521.
25. Mackay, J.P., Gerhard, U., Beauregard, DA., Maplestone, R.A. & Williams, D.H. (1994). Dissection of the contributions toward dimerization of glycopeptide antibiotics. J. Am. Chem. Soc. 116, 4573-4580.
26. Silfhout, R.G. & Hermes, C. (1995). X-ray instrumentation for a focussed wiggler beamline at the EMBL outstation Hamburg. Rev. Sci. Instr. 66, 1818-1820.
27. Otwinowski, Z. & Minor, W. (1996). HKL: a program system for macromolecular data processing. Southwestern Medical Center, University of Texas, Dallas and University of Virginia, Charlottesville, USA.
28. Sheldrick, G.M. & Schneider, T.R. (1997). SHELXL: High-resolution refinement. Methods Enzymol., in press.
29. Engh, R.A. & Huber, R. (1991). Accurate bond and angle parameters for X-ray protein structure refinement. Acta Cryst. A 47, 392-400.
30. McRee, D.E. (1992). A visual protein crystallographic software system for X11/XView. J. Mol. Graph. 10, 44-46.